The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
Background: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality i...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2019-04-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://dia-endojournals.ru/dia/article/viewFile/9630/pdf |
id |
doaj-c7f304c5495742ad8f98f5cc17c006c9 |
---|---|
record_format |
Article |
spelling |
doaj-c7f304c5495742ad8f98f5cc17c006c92021-06-02T19:26:20ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782019-04-01221626910.14341/DM96308644The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathyVictoria A. Serhiyenko0Boris N. Mankovsky1Ludmila М. Serhiyenko2Aleksandr A. Serhiyenko3Danylo Halitsky National Medical UniversityP.L. Shupik National Medical Academy of Postgraduate EducationDanylo Halitsky National Medical UniversityDanylo Halitsky National Medical UniversityBackground: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality in patients with T2DM. Therefore, the problem of effective treatment of CAN is particularly relevant. Aims: To analyze the effect of long-chain polyunsaturated fatty acids (-3 PUFAs) on ambulatory blood pressure monitoring parameters in patients with T2DM and CAN. Materials and methods: 36 patients with T2DM and confirmed CAN were divided into two groups. First group received hypoglycemic therapy (n=15, control) for three months; patients in group 2 (n=21) in addition were administered 1 capsule/q.d. of -3 PUFAs for three month. Results: Treatment with -3 PUFAs led to significant decrease of the diastolic blood pressure (DBP) (p0,01), diastolic blood pressure load (p0,05), time index of DBP (p0,05) during the day; DBP (p0,05), diastolic blood pressure load (p0,05), time index of DBP (p0,05), SD DBP (p0,01) during the night (compared to the control group). Conclusions: The study showed that prescription of -3 PUFAs for three month was effective in decreasing diastolic blood pressure and its parameters among patients with T2DM and CAN.https://dia-endojournals.ru/dia/article/viewFile/9630/pdfdiabetic cardiovascular autonomic neuropathypolyunsaturated fatty acidsambulatory blood pressure monitoring |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Victoria A. Serhiyenko Boris N. Mankovsky Ludmila М. Serhiyenko Aleksandr A. Serhiyenko |
spellingShingle |
Victoria A. Serhiyenko Boris N. Mankovsky Ludmila М. Serhiyenko Aleksandr A. Serhiyenko The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy Сахарный диабет diabetic cardiovascular autonomic neuropathy polyunsaturated fatty acids ambulatory blood pressure monitoring |
author_facet |
Victoria A. Serhiyenko Boris N. Mankovsky Ludmila М. Serhiyenko Aleksandr A. Serhiyenko |
author_sort |
Victoria A. Serhiyenko |
title |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
title_short |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
title_full |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
title_fullStr |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
title_full_unstemmed |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
title_sort |
effect of omega-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
publisher |
Endocrinology Research Centre |
series |
Сахарный диабет |
issn |
2072-0351 2072-0378 |
publishDate |
2019-04-01 |
description |
Background: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality in patients with T2DM. Therefore, the problem of effective treatment of CAN is particularly relevant.
Aims: To analyze the effect of long-chain polyunsaturated fatty acids (-3 PUFAs) on ambulatory blood pressure monitoring parameters in patients with T2DM and CAN.
Materials and methods: 36 patients with T2DM and confirmed CAN were divided into two groups. First group received hypoglycemic therapy (n=15, control) for three months; patients in group 2 (n=21) in addition were administered 1 capsule/q.d. of -3 PUFAs for three month.
Results: Treatment with -3 PUFAs led to significant decrease of the diastolic blood pressure (DBP) (p0,01), diastolic blood pressure load (p0,05), time index of DBP (p0,05) during the day; DBP (p0,05), diastolic blood pressure load (p0,05), time index of DBP (p0,05), SD DBP (p0,01) during the night (compared to the control group).
Conclusions: The study showed that prescription of -3 PUFAs for three month was effective in decreasing diastolic blood pressure and its parameters among patients with T2DM and CAN. |
topic |
diabetic cardiovascular autonomic neuropathy polyunsaturated fatty acids ambulatory blood pressure monitoring |
url |
https://dia-endojournals.ru/dia/article/viewFile/9630/pdf |
work_keys_str_mv |
AT victoriaaserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT borisnmankovsky theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT ludmilamserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT aleksandraserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT victoriaaserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT borisnmankovsky effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT ludmilamserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT aleksandraserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy |
_version_ |
1721401762243411968 |